Clinical Risk Factors for COVID-19 Among People With Substance Use Disorders

Psychiatr Serv. 2020 Dec 1;71(12):1308. doi: 10.1176/appi.ps.202000215. Epub 2020 Oct 6.

Authors

Hefei Wen¹, Michael L Barnett¹, Brendan Saloner¹

Affiliation

¹ Department of Population Medicine, Harvard Medical School, and Harvard Pilgrim Health Care Institute, Boston (Wen); Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston (Barnett); Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore (Saloner). Tami L. Mark, Ph.D., and Alexander J. Cowell, Ph.D., are editors of this column.

PMID: 33019859
DOI: 10.1176/appi.ps.202000215

No abstract available

Keywords: COVID-19; chronic disease; risk factor; substance use disorder.

MeSH terms

Adult
COVID-19* / epidemiology
COVID-19* / prevention & control
COVID-19* / transmission
Communicable Disease Control* / organization & administration
Communicable Disease Control* / statistics & numerical data
Female
Humans
Male
Risk Assessment / methods
Risk Factors
SARS-CoV-2
Substance-Related Disorders* / diagnosis
Substance-Related Disorders* / epidemiology
Substance-Related Disorders* / virology
United States / epidemiology